Literature DB >> 28485158

miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1.

X W Hou, X Sun, Y Yu, H M Zhao, Z J Yang, X Wang, X C Cao.   

Abstract

Lung cancer is the most common type of cancer and the leading cause of death in worldwide. MicroRNAs are known to be key players in a variety of biological processes, including tumorigenesis. In present study, we investigated the effect of miR-361-5p on lung cancer progression. We found that miR-361-5p was down-regulated in lung cancer. Overexpression of miR-361-5p suppressed lung cancer proliferation and invasion. Mechanistically, FOXM1 was identified as a direct target of miR-361-5p. Furthermore, miR-361-5p inhibits EMT-like phenotype through down-regulation of FOXM1 expression in lung cancer cells. In conclusion, our results indicated that miR-361-5p acts as a tumor suppressor in lung cancer.

Entities:  

Keywords:  EMT lung cancer.; FOXM1; miR-361-5p

Mesh:

Substances:

Year:  2017        PMID: 28485158     DOI: 10.4149/neo_2017_406

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  24 in total

1.  MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8.

Authors:  Bingqian Liu; Baiyang Lu; Xue Wang; Haitao Jiang; Weiwei Kuang
Journal:  Childs Nerv Syst       Date:  2019-06-03       Impact factor: 1.475

2.  MicroRNA-21 promotes the proliferation, migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy activity via AMPK/ULK1 signaling pathway.

Authors:  Shuping Li; Xiaofei Zeng; Ruidong Ma; Li Wang
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

3.  MicroRNA-584 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting MTDH.

Authors:  Yixiang Zhang; Yanjun Wang; Jinguang Wang
Journal:  Exp Ther Med       Date:  2017-12-12       Impact factor: 2.751

4.  MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway.

Authors:  Lei Tian; Zhifeng Zhao; Ling Xie; JinPeng Zhu
Journal:  Oncotarget       Date:  2017-12-20

Review 5.  Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer.

Authors:  Antoine Legras; Nicolas Pécuchet; Sandrine Imbeaud; Karine Pallier; Audrey Didelot; Hélène Roussel; Laure Gibault; Elizabeth Fabre; Françoise Le Pimpec-Barthes; Pierre Laurent-Puig; Hélène Blons
Journal:  Cancers (Basel)       Date:  2017-08-03       Impact factor: 6.639

6.  MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.

Authors:  Fei Ma; Lei Zhang; Li Ma; Yiyun Zhang; Jianguo Zhang; Baoliang Guo
Journal:  J Exp Clin Cancer Res       Date:  2017-11-13

7.  Silencing of long non-coding RNA KCNQ1OT1 alleviates LPS-induced lung injury by regulating the miR-370-3p/FOXM1 axis in childhood pneumonia.

Authors:  Ping Wang; Haitao Zhang; Weiqing Zhao; Nini Dai
Journal:  BMC Pulm Med       Date:  2021-07-23       Impact factor: 3.317

8.  MMP1 regulated by NEAT1/miR-361-5p axis facilitates the proliferation and migration of cutaneous squamous cell carcinoma via the activation of Wnt pathway.

Authors:  Shiqiu Jiang; Hairong Liu; Jie Zhang; Fang Zhang; Jiawei Fan; Yueming Liu
Journal:  Cancer Biol Ther       Date:  2021-08-07       Impact factor: 4.875

9.  Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer.

Authors:  Shikai Liu; Lili Song; Hairong Yao; Liang Zhang; Dongkui Xu; Qian Li; Ying Li
Journal:  Dis Markers       Date:  2018-09-23       Impact factor: 3.434

10.  Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma

Authors:  Burhanettin Yalçınkaya; Esra Güzel; Didem Taştekin; Sadrettin Pençe
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.